Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy


You May Also Like

US Department of Defense Reports Travelan Protects Against Shigella in Primates

Key Highlights: Travelan® pre-clinical shigellosis challenge studies in non-human primates (NHP) successfully completedTravelan® prevented ...

HealthLynked Corp. Announces Formation of its Health Advisory Board

NAPLES, Fla., March 15, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK) today announced the formation of ...